In this resource library we share documents, presentations, forms, videos and useful links from Pinnacle and the wider sector.
Use the search box and filters to help find what you're looking for.
Can't find what you need? Try searching in programmes.
There is significant interest by general practice in using AI tools to reduce the amount of time GPs and other practitioners spend on writing up consultations. The following guidance is designed to support AI use in practice.
From support with new role implementation such as primary care assistants (PCAs) to mapping and redesign of current processes such as repeat prescribing processes, your local Pinnacle development manager can support your changing practice needs.
MSD want to work alongside health and disability practitioners to improve opportunities for people now and in the future. Rather than focus on what a person can't do, MSD look at what they can do. MSD will work with providers to get people back to work when they're able.
Jo Scott-Jones and Dave Maplesden discuss prescribing testosterone, medical tourism and ACC treatment injury cover, patient access to their clinical records, and more.
This export includes the service utilisation and clinical event data. This data is a requirement of the PHO agreement and is used for a small number of practices to populate their quality reporting data.
Pinnacle has a Support to Screening referral service in Waikato. The purpose is to provide targeted follow-up, community outreach and support to priority group wāhine, and people with a cervix, who have barriers to accessing cervical screening.
Jo Scott-Jones and Dave Maplesden discuss Measles and SSPE, lymphocytosis, preliminary notice of death, and more.
Approximately 20% of all calls for an ambulance come from a facility with clinically trained staff, such as a medical centre or aged care facility. If the patient has already been assessed by a doctor or a nurse, the caller is asked questions that are quite different (and smaller in number) than when the caller is a member of the public.
Jo Scott-Jones and Dave Maplesden discuss a new prostate cancer care pathway, FIT testing and colorectal symptoms, infrequent zoledronate from early menopause, and more.
Jo Scott-Jones and Dave Maplesden discuss empagliflozin and ketoacidosis, decision to fund fosfomycin in the community, latent autoimmune diabetes and more.